Chondroplasty Market Trends, Analysis And Size Forecast To 2033

The chondroplasty global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Chondroplasty Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size –

The chondroplasty market size has grown strongly in recent years. It will grow from $12.92 billion in 2023 to $13.77 billion in 2024 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increased sports-related injuries, patient preference for non-total joint replacement, postoperative care advances, healthcare provider training and expertise, increasing incidence of joint disorders..

The chondroplasty market size is expected to see strong growth in the next few years. It will grow to $17.29 billion in 2028 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to regenerative medicine integration, focus on outpatient procedures, introduction of novel biomaterials, rise in musculoskeletal disorders, expansion of geriatric population.. Major trends in the forecast period include technological integration in rehabilitation, arthroscopic techniques, cartilage repair and regeneration, technological innovations in surgical tools, integration of navigation systems..

Order your report now for swift delivery @

https://www.thebusinessresearchcompany.com/report/chondroplasty-global-market-report

Scope Of Chondroplasty Market

The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Chondroplasty Market Overview

Market Drivers –

The rising incidence of joint-related disorders is expected to propel the growth of the chondroplasty market going forward. Joint disorders are diseases that affect the health and function of a joint caused by overuse of a joint or a sudden injury, such as an accident or a sports injury. Chondroplasty treats joint-related disorders by repairing the damaged cartilage in a joint. For instance, in August 2023, according to the data published by The Lancet, a UK-based book and periodic data publishing organization, the incidence of gout, an inflammatory arthritis affecting joints, rose from 1.40 diagnoses per 1,000 adults in March 2021 to 1.44 diagnoses per 1,000 adults in March 2022 in the UK. Further, in June 2023, according to the Centers for Disease Control and Prevention, a US-based national public health agency, it is estimated that 78.4 million (25.9%) US adults aged 18 years or older are expected to have doctor-diagnosed arthritis (BRFSS) by 2040. Therefore, the rising incidence of joint-related disorders is driving the growth of the chondroplasty market going forward.

Market Trends –

Major companies operating in the chondroplasty market are developing innovative technologies, such as articular cartilage segmentation tools, to provide reliable customer service. An articular cartilage segmentation tool is a software application that automatically or semi-automatically segments articular cartilage from magnetic resonance imaging (MRI) scans. For instance, in July 2021, RSIP Vision, an Israel-based field-tested software solution, launched the Articular Cartilage Segmentation Tool that delivers an accurate, non-invasive, and automatic assessment of chondral lesions and cartilage-sparing procedures (mosaicplasty, micro-fracture, chondroplasty/osteochondral autograft transfer system, autologous chondrocyte implantation) using deep learning algorithms to segment cartilage from MRI scans automatically. Doctors can more accurately assess an athlete’s cartilage integrity and offer the best cartilage-sparing treatment using the RSIP Vision module, resulting in better outcomes and shorter recovery times.

The chondroplasty market covered in this report is segmented –

1) By Type: Radiofrequency Ablation Chondroplasty, Abrasion Chondroplasty, Atellar Chondroplasty, Meniscal Repair, Tissue Removal, Other Types

2) By Anatomy: Knee, Shoulder, Hip, Other Anatomies

3) By Equipment: Shavers, Radiofrequency Devices, Arthroscope, Other Equipments

4) By End Use: Hospitals, Orthopedic Clinics, Academic Research, Other End Uses

Get an inside scoop of the chondroplasty market, Request now for Sample Report @

https://www.thebusinessresearchcompany.com/sample.aspx?id=13185&type=smp

Regional Insights –

North America was the largest region in the chondroplasty market in 2023. The regions covered in the chondroplasty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Key Companies –

Major companies operating in the chondroplasty market report are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Osiris Therapeutics Inc., Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Medtronic Public Limited Company, Stryker Corporation, Teva Pharmaceutical Industries Ltd., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Sigma-Aldrich Corporation, Arthrex Inc., Bio-Rad Laboratories Inc, QIAGEN N.V., CONMED Corporation, Promega Corporation, Organogenesis Holdings Inc., Bioventus LLC, RTI Surgical Holdings Inc., Vericel Corporation, Geistlich Pharma AG, Ocugen Inc., MEDIPOST Co. Ltd., GPC Medical Ltd., Sklar Surgical Instruments, Isto Biologics, Nebula Inc., NuOrtho Surgical Inc., Medical Devices Business Services Inc.

Table of Contents

1. Executive Summary

2. Chondroplasty Market Report Structure

3. Chondroplasty Market Trends And Strategies

4. Chondroplasty Market – Macro Economic Scenario

5. Chondroplasty Market Size And Growth

…..

27. Chondroplasty Market Competitor Landscape And Company Profiles

28. Key Mergers And Acquisitions

29. Future Outlook and Potential Analysis

30. Appendix

Contact Us: